ModivCare (MODV)
(Real Time Quote from BATS)
$12.11 USD
-0.60 (-4.72%)
Updated Sep 20, 2024 03:00 PM ET
5-Strong Sell of 5 5
D Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
MODV 12.11 -0.60(-4.72%)
Will MODV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MODV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MODV
ModivCare (MODV) Reports Q2 Loss, Misses Revenue Estimates
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
MODV: What are Zacks experts saying now?
Zacks Private Portfolio Services
ModivCare (MODV) Reports Q1 Loss, Tops Revenue Estimates
Alignment Healthcare (ALHC) Surges 17.2%: Is This an Indication of Further Gains?
ModivCare (MODV) Misses Q2 Earnings Estimates
Other News for MODV
ModivCare Inc (MODV) Trading Down 5.98% on Sep 20
Outlook Positive: ModivCare’s Strategic Financial Recovery and Growth Prospects
ModivCare price target lowered by $16 at Barrington, here's why
ModivCare price target lowered by $20 at Lake Street, here's why
Disney, DirecTV agree to restore programming, B+L mulls sale: Morning Buzz